Invention Grant
US08853251B2 Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases
有权
用于治疗视网膜疾病的[3-（1-（1H-咪唑-4-基）乙基）-2-甲基苯基]甲醇的酯前体药
![Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases](/docs/US/2014-10-07/US08853251B2/abs.jpg.600x600.jpg)
- Patent Title: Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases
- Patent Title (中): 用于治疗视网膜疾病的[3-（1-（1H-咪唑-4-基）乙基）-2-甲基苯基]甲醇的酯前体药
-
Application No.: US14071090Application Date: 2013-11-04
-
Publication No.: US08853251B2Publication Date: 2014-10-07
- Inventor: Mohammed I. Dibas , Daniel W. Gil , Ken Chow , Liming Wang , Michael E. Garst , John E. Donello
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- Main IPC: A61K31/415
- IPC: A61K31/415 ; A61K31/4174 ; A61K31/4164 ; C07D233/64
![Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases](/abs-image/US/2014/10/07/US08853251B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
Public/Granted literature
- US20140057958A1 ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING RETINAL DISEASES Public/Granted day:2014-02-27
Information query
